| Name | Lotiglipron |
|---|
| Description | Lotiglipron (PF-07081532) is an orally active GLP-1R agonist. Lotiglipron reduces glucose and body weight, and can be used for research of Type 2 diabetes mellitus (T2DM)[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C31H31ClN4O5 |
|---|---|
| Molecular Weight | 575.05 |